Diabetic Ulcers Disease
Vilacto Bio™ treats a wide range of inflammatory abnormalities, inflammation related disorders (both acute and chronic) and is well within the capacity of our patented properties (Lactoactive®).
We have already overcome notorious healing challenges for some of those concerns, like such wounds, psoriasis, vitiligo, and autoimmune related skin conditions. Our products are currently available on the market as Vilact®. Our aim is to develop new drugs and treatment based on our current treatments to help more people suffering from debilitating skin conditions.
Fast Facts in the USA:
Diabetes was the seventh leading cause of death in the United States in 2013.
29.1 million people or 9.3% of the population have diabetes.
More than a third of American adults—around 86 million—have pre-diabetes, and 90% of them don’t know it.
Approximately 5% of diabetics developing foot ulcers each year and 1% requiring amputation.
A concern in the Latino communities of the Eastern United States, in African Americans, and in Native Americans.
Diabetics are at the highest risk of premature death from ischemic heart disease.
The total cost of treating diabetic foot complications is approaching 11 billion USD.
Global Fast Facts:
The number of people with diabetes has risen from 108 million in 1980 to 422 million in 2014.
The global prevalence of diabetes among adults over 18 years of age has risen from 4.7% in 1980 to 8.5% in 2014.
Diabetes prevalence has been rising more rapidly in middle and low income countries.
In 2012, an estimated 1.5 million deaths were directly caused by diabetes, and another 2.2 million deaths were attributable to high blood glucose.
Almost half of all deaths attributable to high blood glucose occur before the age of 70 years. WHO projects that diabetes will be the 7th leading cause of death in 2030.
It is estimated that the direct annual cost of diabetes around the world is more than US$ 827 billion.
Adjusting for health-care inflation in 2007, foot ulcers cost between $7,439 and $20,622 per episode.
Ulcers and other foot complications are responsible for 20% of the nearly 3 million hospitalizations every year related to diabetes.
It is estimated that 12% of individuals worldwide with a foot ulcer will require amputation.
References
1. http://www.cdc.gov/diabetes/data/
2. http://apps.who.int/iris/bitstream/10665/204871/1/9789241565257_eng.pdf Global report on diabetes 2016
3. Al-Rubeaan K, Al Derwish M, Ouizi S, et al. Diabetic Foot Complications and Their Risk Factors from a Large Retrospective Cohort Study. Santanelli, di Pompeo d’Illasi F, ed. PLoS ONE. 2015;10(5):e0124446. doi:10.1371/journal.pone.0124446.
4. Rodrigues BT, Vangaveti VN, Malabu UH. Prevalence and Risk Factors for Diabetic Lower Limb Amputation: A Clinic-Based Case Control Study. Journal of Diabetes Research. 2016; 2016:5941957. doi:10.1155/2016/5941957.
5. Caroline E. Fife, MD, CWS; Marissa J. Carter, Ph.D., MA; David Walker, CHT; Brett Thomson, BS .Wound Care Outcomes and Associated Cost Among Patients Treated in US Outpatient Wound Centers: Data From the US Wound Registry. WOUNDS 2012; 24(1):10–17.